Olaplex Holdings, Inc.

NasdaqGS:OLPX Stock Report

Market Cap: US$1.2b

Olaplex Holdings Valuation

Is OLPX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OLPX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OLPX ($1.72) is trading below our estimate of fair value ($3.33)

Significantly Below Fair Value: OLPX is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OLPX?

Key metric: As OLPX is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for OLPX. This is calculated by dividing OLPX's market cap by their current earnings.
What is OLPX's PE Ratio?
PE Ratio26.9x
EarningsUS$42.42m
Market CapUS$1.16b

Price to Earnings Ratio vs Peers

How does OLPX's PE Ratio compare to its peers?

The above table shows the PE ratio for OLPX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average19.3x
USNA USANA Health Sciences
13.8x-0.7%US$768.9m
HLF Herbalife
9.2x50.6%US$799.3m
EPC Edgewell Personal Care
17.2x18.8%US$1.7b
HKHC Horizon Kinetics Holding
37xn/aUS$722.1m
OLPX Olaplex Holdings
26.9x3.7%US$1.2b

Price-To-Earnings vs Peers: OLPX is expensive based on its Price-To-Earnings Ratio (26.9x) compared to the peer average (19.3x).

Price to Earnings Ratio vs Industry

How does OLPX's PE Ratio compare vs other companies in the US Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
NEPT.F Neptune Wellness Solutions
n/an/aUS$4.00
No more companies available in this PE range
OLPX 26.9xIndustry Avg. 26.6xNo. of Companies4PE01632486480+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: OLPX is expensive based on its Price-To-Earnings Ratio (26.9x) compared to the North American Personal Products industry average (26.5x).

Price to Earnings Ratio vs Fair Ratio

What is OLPX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OLPX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio26.9x
Fair PE Ratio17.7x

Price-To-Earnings vs Fair Ratio: OLPX is expensive based on its Price-To-Earnings Ratio (26.9x) compared to the estimated Fair Price-To-Earnings Ratio (17.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OLPX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$1.72
US$2.29
+33.4%
45.5%US$5.00US$1.50n/a9
Nov ’25US$1.85
US$2.56
+38.4%
37.2%US$5.00US$2.00n/a9
Oct ’25US$2.33
US$2.56
+9.9%
37.2%US$5.00US$2.00n/a9
Sep ’25US$2.09
US$2.56
+22.5%
37.2%US$5.00US$2.00n/a9
Aug ’25US$1.91
US$2.36
+23.3%
42.8%US$5.00US$1.50n/a9
Jul ’25US$1.54
US$2.36
+53.0%
42.8%US$5.00US$1.50n/a9
Jun ’25US$1.78
US$2.36
+32.3%
42.8%US$5.00US$1.50n/a9
May ’25US$1.40
US$2.63
+88.1%
66.9%US$7.50US$1.50n/a9
Apr ’25US$1.94
US$2.69
+38.9%
64.2%US$7.50US$1.80n/a9
Mar ’25US$1.82
US$2.61
+43.5%
68.2%US$7.50US$1.25n/a9
Feb ’25US$2.35
US$3.13
+33.0%
67.0%US$7.50US$1.50n/a10
Jan ’25US$2.54
US$3.10
+21.9%
68.2%US$7.50US$1.50n/a10
Dec ’24US$2.35
US$3.02
+28.5%
71.0%US$7.50US$1.50n/a10
Nov ’24US$1.36
US$3.56
+161.7%
53.0%US$7.50US$1.75US$1.8511
Oct ’24US$1.95
US$3.76
+93.0%
46.4%US$7.50US$2.00US$2.3311
Sep ’24US$2.68
US$3.76
+40.4%
46.4%US$7.50US$2.00US$2.0911
Aug ’24US$3.46
US$5.84
+68.8%
59.0%US$15.00US$3.00US$1.9111
Jul ’24US$3.72
US$5.77
+55.1%
57.3%US$15.00US$3.00US$1.5412
Jun ’24US$3.21
US$5.77
+79.8%
57.3%US$15.00US$3.00US$1.7812
May ’24US$3.69
US$6.46
+75.1%
47.7%US$15.00US$4.00US$1.4013
Apr ’24US$4.27
US$6.46
+51.3%
47.7%US$15.00US$4.00US$1.9413
Mar ’24US$4.58
US$6.42
+40.1%
35.1%US$10.00US$4.00US$1.8212
Feb ’24US$6.57
US$7.67
+16.7%
27.8%US$11.00US$5.00US$2.3512
Jan ’24US$5.21
US$7.58
+45.6%
28.2%US$11.00US$5.00US$2.5412
Dec ’23US$6.02
US$7.58
+26.0%
28.2%US$11.00US$5.00US$2.3512
Nov ’23US$4.52
US$7.95
+76.0%
25.5%US$11.00US$5.00US$1.3611

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

Reynolds Consumer Products

US$5.7b

Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.

REYN

US$27.47

7D

-0.3%

1Y

3.8%

USANA Health Sciences

US$768.9m

Develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.

USNA

US$39.38

7D

-4.6%

1Y

-14.8%

Kimberly-Clark de México S. A. B. de C. V

Mex$86.8b

Manufactures, distributes, and sells disposable products in Mexico.

KCDM.Y

Mex$7.05

7D

-0.3%

1Y

-30.2%